#lungcancer
The #WeekInOncology by OncoAlert 🚨 Dr. Uğur Özkerim 🇹🇷 breaks down his top #LungCancer 🫁 picks: 📊 PACIFIC trial post hoc analysis (Lancet Oncology) 📰 KRAScendo-1 industry update Top trials. Top faculty. Every week. Only on OncoAlert 👇 PACIFIC Link KRAScendo 1 Update (from Industry) Pinging Our🚨 Lung Cancer Faculty Solange Peters Christine Lovly, MD, PhD, FASCO gilberto lopes Sanjay Popat Stephen V Liu, MD Henning Willers, MD, FASTRO Hidehito HORINOUCHI Biagio Ricciuti, MD, PhD Percy Lee, MD, MBA Jill Feldman Ben Solomon Dr. Estela Rodriguez Jarushka Naidoo Fabrice Barlesi Uğur Özkerim Jose Fernando Moura, PhD Oriol Mirallas MD Vanita Noronha, MBBS MD DM Narjust Florez, MD, FASCO Martin Reck
OncoAlert12,239 просмотров • 1 месяц назад
క్యాన్సర్కు కొత్త ఇంజెక్షన్ ఏడు నిమిషాల్లోనే.. #cancer #Lungcancer #etvdigital
ETV Andhra Pradesh26,609 просмотров • 2 месяцев назад
They Cut the Cancer Out—But THIS Saved Me🙏 I did it! I’m in recovery ❤️🩹 now and when I’m better I’ll share more in detail. Thanks for everyone who has been praying for me and my family. Stay tuned much to share! President Trump 45 Archived ⁿᵉʷˢ Robert F. Kennedy Jr. Dr. Mehmet Oz #lungcancer #survivor #jesussaves #faith
Patty Hatfield21,530 просмотров • 4 месяцев назад
Day 1 of #ASCO26 delivered practice-changing data across #LungCancer #BladderCancer #KidneyCancer Captured by the OncoAlert 🚨 Round Up 🔹 7-year CROWN update confirms unprecedented durability with lorlatinib in ALK+ NSCLC Tony Mok 🔹 ADC + immunotherapy combination shows major frontline promise in NSCLC 🔹 Sunvozertinib emerges as a new first-line standard for EGFR exon20ins disease 🔹 EV-302 continues to redefine survival in metastatic urothelial carcinoma Tom Powles 🔹 ctDNA analyses from KEYNOTE-564 move us closer to precision adjuvant RCC care Toni Choueiri, MD Catch all the key studies and clinical insights in the latest OncoAlert ASCO 2026 Day 1 Roundup. 🎧 Listen now and stay ahead of the science. #ASCO26 Stephen V Liu, MD Yüksel Ürün Uğur Özkerim Oncology Brothers Sakditad “Tew” Saowapa, MD Dr Rishabh Jain Masahiro TORASAWA, MD. PhD. Ahmed Alanazi | أحمد العنزي David Heredia. Allison Chang Rami Manochakian MD, FASCO Cancer Education 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Rohit Singh, MD Diego A. Díaz-García Tuğba Başoğlu, MD Oriol Mirallas MD Johan Pluvy | Thoracic Oncology News gilberto lopes José Márcio Barros de Figueiredo MD, MSc Hidehito HORINOUCHI Jordi Remon Manuel Dómine, MD, PhD Dr Amol Akhade ilyas sahin, MD Tom Powles Toni Choueiri, MD Dra. María Natalia Gandur Quiroga Shilpa Gupta Emre Yekedüz Shreyas Kalantri, MD Elisabetta Bonzano MD, PhD Zach Klaassen Mario Balsa Wassim Daoud Khatoun Katy Beckermann Andres Meraz-Brenez Fuat Bicer MD, PhD Arpita Desai Javier Puente
OncoAlert10,985 просмотров • 2 месяцев назад
🔬 A treatment discovered through a collaboration between MSK computational biologist Dr. dana_peer and MSK neuro-oncologist Dr. Adrienne Boire, has given Carlos, an MSK stage 4 #lungcancer patient, more time with his family and a much better quality of life. Watch more stories on YouTube: #cancerresearch
Memorial Sloan Kettering Cancer Center17,718 просмотров • 6 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 26-Oct 2, 2025 REGISTER at OR Discussing: 🫁 #LungCancer/ Immunotherapy ✅Dual CTLA-4 + PD-L1/PD-1 Blockade Shows No OS Advantage Overall but Boosts Outcomes in PD-L1–Low & STK11-Mutant NSCLC ✅Neoadjuvant/Perioperative Immunotherapy Outperforms Adjuvant in Resectable NSCLC, Even in PD-L1–Negative and Squamous Tumors 🩺 #BreastCancer ✅Trastuzumab Deruxtecan Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer (DESTINY-Breast05) NEWS FROM INDUSTRY ✅Adjuvant Ribociclib + Aromatase Inhibitor Maintains 4-Year iDFS Benefit in HR+/HER2– Early Breast Cancer (NATALEE Trial) ✅Sacituzumab Govitecan: Effective for Advanced TNBC & HR+/HER2– Breast Cancer With Practical AE Management Strategies ✅Higher BMI Amplifies Postmenopausal Breast Cancer Risk—Especially in Women With Cardiovascular Disease GI / #GastricCancer ✅Early-Onset Transient Gastritis Common With First-Line Zolbetuximab in CLDN18.2+ Gastric Cancer ✅CLDN18.2 Expression in Gastric Cancer Is Dynamic During Chemoimmunotherapy, Linked to Immune-Inflamed Stroma and Outcomes 🧬 GU / #ProstateCancer ✅Prostate Cancer Germline Testing: Phone or Physician Counseling Boosts Satisfaction; Asian American Men Report Lower Satisfaction (PROGRESS Registry) 🧠 Mental Health / Survivorship ✅Cancer Survivors Use Antidepressants and Anxiolytics More Than Noncancer Peers—With Persistent Racial and Insurance Disparities 🧠 Gyn / #EndometrialCancer ✅“Aggressive” Histology Predicts Prognosis in Surgically Staged, Clinically Uterine-Confined Endometrial Carcinoma Alessandro Di Federico Andrea De Giglio, MD PhD Stephen V Liu, MD Bartomeu Massuti Ke Xin Erika Hamilton, MD, FASCO Stephanie A. Haddad, DO Alexis LeVee, MD Armando Orlandi Jame Abraham, MD, FACP JAMA Oncology Dr Rishabh Jain Sergio Cifuentes Angel Lopez-Galindo, MD, MHA Elvina Almuradova ACS Journal Cancer CA: A Cancer Journal for Clinicians Heinz Freisling IARC Joel "Heart Prevention" Kahn MD, FACC Nieves Martinez Lago MD PhD Kohei shitara Faisal Scientist JAMA Network Open Dr Joseph McCollom DO Duke TORCHE Mario M. Leitao, Jr Christian Dagher Ziyi Matteo Lambertini, MD PhD Icro Meattini Hope Rugo
OncoAlert24,835 просмотров • 10 месяцев назад
Great to be out for a walk in nature, a few days after robot-assisted lobectomy for #lungcancer. One pill a day targeted therapy killed cancerous tumors and nodes in both lungs. Removing lobe where cancer originated, continuing pill helps it not come back. ❤️to all.
Neal Augenstein37,749 просмотров • 3 лет назад